Growth Equity Opportunities IV, LLC → ARCA biopharma, Inc. ORKA

Stake: — Shares: —

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

1 transaction

0 buys · 0 sales · 1 awards/exercises

Issuer Cluster

3 13D/G filings on this issuer

2 other filings besides this one

Filer Track Record

3 filings by this filer

2 other filings in the data moat

Short Interest · settle 2026-03-31

DTC 5.02

4,522,980 shares short · +24.1% vs prior

Form 4 Insider Transactions · last 365d

Date	Insider	Role	Type	Shares	Price	Value
2026-04-15	Goncalves Joana	officer	Option exercise	3,500	$6.84	$24K

Other 13D/G Filings on ARCA biopharma, Inc.

Filed	Form	Filer	Stake	Shares
2025-03-10	SCHEDULE	Fairmount Funds Management LLC	19.99%	8,511,824	view →
2018-01-04	SC	SABBY MANAGEMENT, LLC	—	—	view →

Other Filings by Growth Equity Opportunities IV, LLC

Filed	Form	Issuer	Stake	Shares
2025-01-21	SCHEDULE	Verona Pharma plc	4.99%	32,679,649	view →
2018-03-19	SC	Cascadian Therapeutics, Inc.	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. $1,500/mo. Pilots welcome.

Request a pilot →